Publications
83
Citations
591
Est. group size
~8
Recurring co-author estimate
Active years
23
Publishing since 2004
Takahiko Sakaue's work focuses on liver, pancreatic, and bile-duct cancers, studying the molecular mechanisms that drive tumor growth, treatment resistance, and immune evasion, alongside clinical endoscopy techniques for diagnosing and treating pancreato-biliary diseases. Research spans laboratory studies (e.g., microRNAs, cell signaling, immune cell therapies) and clinical/procedural topics such as endoscopic retrograde cholangiopancreatography (ERCP) techniques and case reports. This combination suggests a translational research program bridging basic cancer biology with hands-on gastroenterology practice.
Publication output was relatively steady at 2-6 papers per year from 2017-2022, then rose sharply in 2023 (23 publications) before settling to a more moderate but still elevated pace through 2024-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- The Usefulness of Short‐Type Single Balloon Enteroscope for Successful Pancreato‐Biliary Cannulation During Endoscopic Retrograde Cholangiopancreatography in Patients With Roux‐en‐Y Gastrectomy: A Comparative Study With Short‐Type Double‐balloon Enteroscope
DEN Open · 2026
- A Continuous Metallic Stream: Endoscopic Salvage of Migrated Hepatic Artery Coils
The American Journal of Gastroenterology · 2026
- Abstract 1919: Development of a diagnostic method for early-stage pancreatic cancer through exosome-derived microRNA profiling
Cancer Research · 2025
- Abstract 6674: Leucine sensing and mTOR activation drive SNAIL-mediated EMT in pancreatic cancer cells
Cancer Research · 2025
- Association between nonalcholic fatty liver disease and pancreatic cancer: Epidemiology, mechanisms, and antidiabetic medication
Hepatology Research · 2024
- A tumor endothelial cell-specific microRNA replacement therapy for hepatocellular carcinoma
iScience · 2024
- Ex-vivo expanded CD34+ cell transplantation alleviates fibrotic liver injury via innate immune modulation in metabolic dysfunction-associated steatohepatitis mice
Cytotherapy · 2024
- Abstract 4393: Expression levels of T-cell factor-4 variants in hepato-gastrointestinal cancer cells and tissues
Cancer Research · 2024
- Bile duct wall thickening in a 62-year-old man
Frontline Gastroenterology · 2024
- Tumor‐derived insulin‐like growth factor‐binding protein‐1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors
Cancer Communications · 2023
- Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma
Hepatology International · 2023
- Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1–AXL signal relay in liver cancer cells
Hepatology International · 2023
- Suppl-Figure 3 from Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1
2023
- Suppl-Figure 1 from Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1
2023
- Suppl-Figure 2 from Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1
2023
- Cancer Research×17
- Cancers×2
- Cancer Communications×2
- Hepatology International×2
- Oncogene×2
- Stuart D. Wilson
Medicine · The Ohio State University
- Iván González
Medicine · Indiana University
- Bhavana Konda
Medicine · The Ohio State University
- Chloe Holden
Medicine · Indiana University
- Ashima Goyal
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile